D757-0255 Screening compound: trans-4-[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-N-[(1-phenyl-1H-tetrazol-5-yl)methyl]cyclohexanecarboxamide

D757-0255 Screening compound: trans-4-[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-N-[(1-phenyl-1H-tetrazol-5-yl)methyl]cyclohexanecarboxamide
D757-0255 Screening compound: trans-4-[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-N-[(1-phenyl-1H-tetrazol-5-yl)methyl]cyclohexanecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D757-0255
trans-4-[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-N-[(1-phenyl-1H-tetrazol-5-yl)methyl]cyclohexanecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D757-0255

Molecular Formula

C24H26N6O2 (C24 H26 N6 O2)

Compound Name

trans-4-[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-N-[(1-phenyl-1H-tetrazol-5-yl)methyl]cyclohexanecarboxamide

IUPAC name

(1r4r)-4-[(1-oxo-23-dihydro-1H-isoindol-2-yl)methyl]-N-[(1-phenyl-1H-1234-tetrazol-5-yl)methyl]cyclohexane-1-carboxamide

SMILES

O=C([C@H]1CC[C@H](CN(Cc2c3cccc2)C3=O)CC1)NCc1nnnn1-c1ccccc1

InChI

InChI=1S/C24H26N6O2/c31-23(25-14-22-26-27-28-30(22)20-7-2-1-3-8-20)18-12-10-17(11-13-18)15-29-16-19-6-4-5-9-21(19)24(29)32/h1-9,17-18H,10-16H2,(H,25,31)

InChI Key

BISMDWYYDCCBIQ-UHFFFAOYSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

430.51

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.770

Distribution Coefficient, logD

2.770

Water Solubility, LogSw

-3.48

Polar Surface Area

81.807

Acid Dissociation Constant (pKa)

13.54

Base Dissociation Constant (pKb)

-2.93

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.50

D757-0255 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

PLpro Library (6343 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with D757-0255 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D757-0255?
Check Price and Availability of D757-0255, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D757-0255 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D757-0255
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D757-0255
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D757-0255 available by request